Cui X, Pertile R, Liu P, Eyles D W
Queensland Brain Institute, University of Queensland, Qld 4072, Australia.
Queensland Brain Institute, University of Queensland, Qld 4072, Australia; Queensland Centre for Mental Health Research, Wacol, Qld 4076, Australia.
Neuroscience. 2015 Sep 24;304:90-100. doi: 10.1016/j.neuroscience.2015.07.048. Epub 2015 Jul 23.
Vitamin D is a neuroactive steroid. Its genomic actions are mediated via the active form of vitamin D, 1,25(OH)2D3, binding to the vitamin D receptor (VDR). The VDR emerges in the rat mesencephalon at embryonic day 12, representing the peak period of dopaminergic cell birth. Our prior studies reveal that developmental vitamin D (DVD)-deficiency alters the ontogeny of dopaminergic neurons in the developing mesencephalon. There is also consistent evidence from others that 1,25(OH)2D3 promotes the survival of dopaminergic neurons in models of dopaminergic toxicity. In both developmental and toxicological studies it has been proposed that 1,25(OH)2D3 may modulate the differentiation and maturation of dopaminergic neurons; however, to date there is lack of direct evidence. The aim of the current study is to investigate this both in vitro using a human SH-SY5Y cell line transfected with rodent VDR and in vivo using a DVD-deficient model. Here we show that in VDR-expressing SH-SY5Y cells, 1,25(OH)2D3 significantly increased production of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis. This effect was dose- and time-dependent, but was not due to an increase in TH-positive cell number, nor was it due to the production of trophic survival factors for dopamine neurons such as glial-derived neurotrophic factor (GDNF). In accordance with 1,25(OH)2D3's anti-proliferative actions in the brain, 1,25(OH)2D3 reduced the percentage of dividing cells from approximately 15-10%. Given the recently reported role of N-cadherin in the direct differentiation of dopaminergic neurons, we examined here whether it may be elevated by 1,25(OH)2D3. We confirmed this in vitro and more importantly, we showed DVD-deficiency decreases N-cadherin expression in the embryonic mesencephalon. In summary, in our in vitro model we have shown 1,25(OH)2D3 increases TH expression, decreases proliferation and elevates N-cadherin, a potential factor that mediates these processes. Accordingly all of these findings are reversed in the developing brain in our DVD-deficiency model. Remarkably our findings in the DVD-deficiency model phenocopy those found in a recent model where N-cadherin was regionally ablated from the mesencephalon. This study has, for the first time, shown that vitamin D directly modulates TH expression and strongly suggests N-cadherin may be a plausible mediator of this process both in vitro and in vivo. Our findings may help to explain epidemiological data linking DVD deficiency with schizophrenia.
维生素D是一种具有神经活性的类固醇。其基因组作用是通过维生素D的活性形式1,25(OH)2D3与维生素D受体(VDR)结合来介导的。VDR在胚胎第12天出现在大鼠中脑,这是多巴胺能细胞生成的高峰期。我们之前的研究表明,发育性维生素D(DVD)缺乏会改变发育中脑内多巴胺能神经元的个体发生。也有其他研究提供的一致证据表明,在多巴胺能毒性模型中,1,25(OH)2D3可促进多巴胺能神经元的存活。在发育和毒理学研究中都有人提出,1,25(OH)2D3可能调节多巴胺能神经元的分化和成熟;然而,迄今为止缺乏直接证据。本研究的目的是在体外使用转染了啮齿动物VDR的人SH-SY5Y细胞系,以及在体内使用DVD缺乏模型来对此进行研究。在此我们表明,在表达VDR的SH-SY5Y细胞中,1,25(OH)2D3显著增加了酪氨酸羟化酶(TH)的产生,TH是多巴胺合成中的限速酶。这种作用具有剂量和时间依赖性,但并非由于TH阳性细胞数量增加,也不是由于产生了多巴胺能神经元的营养性存活因子,如胶质细胞源性神经营养因子(GDNF)。与1,25(OH)2D3在脑中的抗增殖作用一致,1,25(OH)2D3将分裂细胞的百分比从约15%降低至10%。鉴于最近报道N-钙黏蛋白在多巴胺能神经元的直接分化中起作用,我们在此研究了它是否可能被1,25(OH)2D3上调。我们在体外证实了这一点,更重要的是,我们发现DVD缺乏会降低胚胎中脑中N-钙黏蛋白的表达。总之,在我们的体外模型中,我们表明1,25(OH)2D3增加TH表达、减少增殖并上调N-钙黏蛋白,N-钙黏蛋白是介导这些过程的一个潜在因子。因此,在我们的DVD缺乏模型中,发育中的大脑里所有这些发现都被逆转了。值得注意的是,我们在DVD缺乏模型中的发现与最近一个模型中的发现相似,在该模型中N-钙黏蛋白在中脑被局部切除。这项研究首次表明维生素D直接调节TH表达,并强烈提示N-钙黏蛋白可能在体外和体内都是这一过程的合理介质。我们的发现可能有助于解释将DVD缺乏与精神分裂症联系起来的流行病学数据。